Lifevantage Corporation Declares Quarterly Dividend of $0.05 (NASDAQ:LFVN)

Lifevantage Corporation (NASDAQ:LFVN) announced a quarterly dividend on Wednesday, February 4th. Shareholders of record on Monday, March 2nd will be given a dividend of 0.045 per share on Monday, March 16th. This represents a c) annualized dividend and a yield of 4.0%. The ex-dividend date is Monday, March 2nd.

Lifevantage has a dividend payout ratio of 16.7% meaning its dividend is sufficiently covered by earnings.

Lifevantage Trading Down 19.5%

Shares of Lifevantage stock traded down $1.08 during trading on Thursday, hitting $4.47. 274,187 shares of the stock were exchanged, compared to its average volume of 233,016. The company has a fifty day moving average price of $6.22 and a 200-day moving average price of $8.96. The stock has a market capitalization of $56.72 million, a price-to-earnings ratio of 6.11 and a beta of 0.33. Lifevantage has a 1-year low of $3.90 and a 1-year high of $22.49.

Lifevantage (NASDAQ:LFVN) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). Lifevantage had a return on equity of 33.52% and a net margin of 4.43%.The business had revenue of $48.93 million for the quarter, compared to the consensus estimate of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.